Join to View Full Profile
35 Park StreetNew Haven, CT 06510
Phone+1 617-632-6876
Fax+1 617-632-1930
Dr. Winer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Hematology and Medical Oncology, 1987 - 1989
Yale-New Haven Medical CenterResidency, Internal Medicine, 1984 - 1987- Yale-New Haven Medical CenterInternship, Internal Medicine, 1983 - 1984
Yale School of MedicineClass of 1983
Certifications & Licensure
ME State Medical License Current
CT State Medical License 2021 - 2025
MA State Medical License 1997 - 2023
NC State Medical License 1987 - 1999
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2002-2014
- Boston Magazine Castle Connolly, 2008-2013
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Join now to see all
Clinical Trials
- Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases Start of enrollment: 2004 Oct 01
- Educational Interventions for Patients With DCIS Start of enrollment: 2003 May 01
- Preoperative Herceptin/Navelbine Versus Taxotere/Carboplatin/Herceptin in HER-2 Positive Breast Cancer Start of enrollment: 2003 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Association of potential biomarkers with clinical outcomes in metastatic triple-negative breast cancer treated with pembrolizumab or chemotherapy.Javier Cortes, Oleg Lipatov, Seock-Ah Im, Anthony Goncalves, Keun Seok Lee
NPJ Breast Cancer. 2025-10-02 - 1 citationsImpact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) Trial.Jennifer A Ligibel, Karla V Ballman, Linda McCall, Pamela J Goodwin, Catherine M Alfano
JAMA Oncology. 2025-10-01 - Detection of heterogeneous resistance mechanisms to tyrosine kinase inhibitors from cell-free DNA.Heather A Parsons, Conor Messer, Katheryn Santos, Jakob Weiss, David Merrell
Cell Genomics. 2025-09-09
Journal Articles
- Individualizing Surveillance Mammography for Older Patients After Treatment for Early-Stage Breast CancerEric P Winer, Louise C Walter, Mina S Sedrak, Tanya M Wildes, Stuart M Lichtman, Kathryn J Ruddy, JAMA Oncology
- Effect of Eribulin with or Without Pembrolizumab on Progression-Free Survival for Patients with Hormone Receptor–Positive, ERBB2-Negative Metastatic Breast CancerSara M Tolaney, Gerburg Wulf, Laura Spring, Beth Overmoyer, Ann H Partridge, Eric P Winer, Ian E Krop, JAMA Oncology
- Pembrolizumab Monotherapy for Previously Untreated, PD-L1-Positive, Metastatic Triple-Negative Breast Cancer: Cohort B of the Phase II KEYNOTE-086 StudyM C Liu, R Nanda, H S Rugo, E P Winer, S Adams, Annals of Oncology
- Join now to see all
Lectures
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/11/2013
- 35th Annual CTRC-AACR San Antonio Breast Cancer Symposium(SABCS)UT Health Science Center San Antonio, San Antonio, Texas - 12/4/2012
- Breast Cancer, New Horizons, Current ControversiesHarvard Medical School, Boston, Massachusetts - 7/12/2012
Press Mentions
This 25-Year-Old Survived Breast Cancer. Now, She's Dealing with MenopauseJuly 31st, 2025- Researchers Aim to Adapt Metastatic Breast Cancer Therapy as Tumors ChangeJuly 2nd, 2025
- Improved Breast Cancer Outcomes with Less Invasive SurgeryMay 5th, 2025
- Join now to see all
Grant Support
- Immune Dysfunction in HIV associated Lung Cancer (Immuno/Microenvironment)YALE UNIVERSITY1997–2029
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Cancer Center Support GrantYALE UNIVERSITY1997–2029
- Immune Dysfunction in HIV associated Lung Cancer (Immuno/Microenvironment)YALE UNIVERSITY1997–2029
- Clinical Studies CoreNational Cancer Institute2008–2009
- Cancer And Leukemia Group BNational Cancer Institute2006–2008
- C-2: Clinical Study CoreNational Cancer Institute2005–2007
- Psychosocial Outcomes/Health Behaviors: Women With DCISNational Cancer Institute2000–2002
- Tailored Information Materials About BRCA1 TestingNational Cancer Institute1995–1996
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
